http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8436195-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_601c1203d074153e89f4858f93e5cb66
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09B11-10
filingDate 2006-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b06abd7df4f9cd8967f0d6c22a9316d4
publicationDate 2013-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-8436195-B2
titleOfInvention Use of malachite green oxalate for treating malignant neoplasms
abstract The use of malachite green in the form of a tetramethyldiamino-triphenyl-carbinol anhydro-oxalate [(C 23 H 25 N 2 )—(C 2 HO 4 )] 2 —C 2 H 2 O 4 of the following structural formula as a drug for treating malignant neoplasms administered in a single dose of 1 to 2 g. Malachite green can be used when dissolved in an aqueous solution or in a physiological salt solution or in spirit. In different cases, the malachite green solution is perorally administered before and after a meal or is injected per rectum, or a 1% malachite green solution is intravenously introduced, or the malachite green is applied as a rectal suppository component or as a component of 1-5% ointment. The medicinal agent exhibits an extended range of therapeutic actions with respect to different oncological diseases, is freely available, not expensive, non-toxic, does not generate side effects when used in pharmaceutically acceptable doses, and makes it possible to reduce a treating time and to increase the efficiency of treatment.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9567291-B2
priorityDate 2006-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6331564-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2532206-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2084604-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003114403-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59294074
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452776522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160922267
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5497144
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59931723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID237182470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID239889079
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229343601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68593561
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466863442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54004060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415608
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID323342554

Total number of triples: 43.